Progressive Supranuclear Palsy Clinical Trials

149 clinical trials for Progressive Supranuclear Palsy across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia — RECRUITING
• The Progressive Supranuclear Palsy Clinical Trial Platform — RECRUITING · PHASE2
• ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) — RECRUITING
• Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders — RECRUITING · NA
• Neurologic Stem Cell Treatment Study — RECRUITING · NA
• A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy — RECRUITING · NA
• Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases — RECRUITING · NA
• The Swedish BioFINDER 2 Study — RECRUITING · NA
• Synaptic Loss in Multiple System Atrophy — RECRUITING
• Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers — RECRUITING
• Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging — RECRUITING
• UPenn Observational Research Repository on Neurodegenerative Disease — RECRUITING
• The CurePSP Genetics Program — RECRUITING
• tDCS as Treatment for Motor Function — RECRUITING · NA
• Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling — RECRUITING
• Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology — RECRUITING · NA
• AI-Enhanced Optimization of Acute Levodopa Challenge Test — RECRUITING
• Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases — RECRUITING
• Diagnosing Frontotemporal Lobar Degeneration — RECRUITING
• Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely — RECRUITING · NA
• NYSCF Scientific Discovery Biobank — RECRUITING
• The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism — RECRUITING · PHASE2
• The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders — RECRUITING · NA
• Utilisation of Health Services and Quality of Life in Patients With Atypical Parkinsonian Syndromes — RECRUITING
• Modifiable Variables in Parkinsonism (MVP) — RECRUITING
• A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to assess the Efficacy, Tolerability and Safety of Rasagiline in Subjects with Progressive Supranuclear Palsy (Phase III) — TERMINATED · PHASE3
• A Phase 2/3, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy. — COMPLETED · PHASE3
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study — ACTIVE_NOT_RECRUITING
• Art Therapy in Progressive Supranuclear Palsy — ACTIVE_NOT_RECRUITING · NA
• A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy — ACTIVE_NOT_RECRUITING · PHASE1
• Automated Imaging Differentiation of Parkinsonism — ACTIVE_NOT_RECRUITING
• Remote Monitoring in Progressive Supranuclear Palsy (PSP) — NOT_YET_RECRUITING
• Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL) — ACTIVE_NOT_RECRUITING · NA
• First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain — COMPLETED · PHASE1
• Gait Analysis in Neurological Disease — ACTIVE_NOT_RECRUITING
• Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies — NOT_YET_RECRUITING
• Trial of Parkinson's And Zoledronic Acid — COMPLETED · PHASE4
• Research of Biomarkers in Parkinson Disease — COMPLETED
• Biomarkers in Parkinsonian Syndromes — ACTIVE_NOT_RECRUITING
• Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes — NOT_YET_RECRUITING
• A randomized, double-blind, placebo-controlled, Phase 2 study to assess the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) to slow the disease progression of progressive supranuclear palsy (PSP) PROSPER — TERMINATED · PHASE2
• AMX0035 and Progressive Supranuclear Palsy — COMPLETED · PHASE2
• An Open-Label Extension Study to Evaluate the Safety and Tolerability of Long-Term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy — TERMINATED · PHASE1
• A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) — COMPLETED · PHASE2
• Community Outreach for Palliative Engagement -- Parkinson Disease — ACTIVE_NOT_RECRUITING · NA
• GV1001 Subcutaneous(SC) for the Treatment of Progressive Supranuclear Palsy (PSP) — COMPLETED · PHASE2
• A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes — ACTIVE_NOT_RECRUITING
• Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy — COMPLETED · PHASE1
• Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011 — COMPLETED · PHASE2
• A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search